You’ve worked hard to get this far. Rely on Inotiv’s scientific leadership and attentive, decisive advice to uncover potential flaws in your novel pharmaceutical compound that might limit its development — before you invest significant time and money.
Think of our consulting services as an extension of your own team. We’ll design and execute an efficacious preclinical development program seamlessly aligned to your needs and goals. Our exploratory preclinical safety evaluations identify dose/exposure relationships for tolerability. They also point out relevant organs and/or systems that may be susceptible to adverse pharmacology or toxicology.
Inotiv’s commitment to scientific continuity means you will work with the same dedicated team throughout your compound’s development journey. With the expertise and insights of our program managers who are intimately involved in the process — throughout its duration — you’ll feel confident in the multitude of decisions you must make.
Talk to us about how we can put our experience and expertise to work for you in: